|Andy Boral||Chief Medical Officer|
|Mike Landsittel||VP of Finance|
|Marion Dorsch||Chief Scientific Officer|
|Terence Flynn||Goldman Sachs|
|Laura Chico||Raymond James|
|Marc Frahm||Cowen and Company|
|Konstantinos Aprilakis||JMP Securities|
|Arlinda Lee||Canaccord Genuity|
Good day, ladies and gentlemen, and welcome to the Second Quarter 2018 Blueprint Medicines Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions].
As a reminder, this conference call may be recorded.